As discussed in a recent review [64] a range of studies are required to demonstrate that such candidate blood biomarkers for DMD are robust, and relate to the extent of myonecrosis in animal models of DMD, as demonstrated here for in Cys34 albumin in response to exercise, and in taurine treated young mdx mice. Here, ALB is linked to Duchenne muscular dystrophy.